MENU
+Compare
KRYS
Stock ticker: NASDAQ
AS OF
Oct 22, 12:36 PM (EDT)
Price
$187.34
Change
-$3.44 (-1.80%)
Capitalization
5.52B

KRYS Krystal Biotech Forecast, Technical & Fundamental Analysis

Krystal Biotech Inc is engaged in the healthcare sector in the United States... Show more

KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KRYS with price predictions
Oct 21, 2025

KRYS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for KRYS moved above the 200-day moving average on October 13, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for KRYS crossed bullishly above the 50-day moving average on September 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KRYS advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where KRYS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KRYS moved out of overbought territory on October 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for KRYS turned negative on October 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRYS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KRYS broke above its upper Bollinger Band on October 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KRYS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.305) is normal, around the industry mean (23.690). P/E Ratio (38.776) is within average values for comparable stocks, (54.778). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.163). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (15.873) is also within normal values, averaging (355.294).

View a ticker or compare two or three
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KRYS is expected to report earnings to fall 15.50% to $1.09 per share on November 10

Krystal Biotech KRYS Stock Earnings Reports
Q3'25
Est.
$1.09
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.31
Q3'24
Missed
by $0.08
The last earnings report on August 04 showed earnings per share of $1.29, beating the estimate of $1.22. With 26.27K shares outstanding, the current market capitalization sits at 5.52B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which provides therapies for rare and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
229
Web
https://www.krystalbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMVYX18.42N/A
N/A
Hartford MidCap Value Y
SMISX34.56N/A
N/A
Invesco Summit R6
VIEIX160.73N/A
N/A
Vanguard Extended Market Index Instl
ASRFX8.45N/A
N/A
Invesco Global Real Estate Income R6
DPRSX13.57-0.11
-0.80%
Macquarie Global Listed Real Assets Inst

KRYS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.64%
VRDN - KRYS
52%
Loosely correlated
-0.29%
ACLX - KRYS
50%
Loosely correlated
-1.33%
CGON - KRYS
49%
Loosely correlated
-1.22%
NUVL - KRYS
49%
Loosely correlated
-0.81%
XNCR - KRYS
49%
Loosely correlated
-3.72%
More